Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Amy

Paller

,

MS, MD

Walter J. Hamlin Professor and Chair
Northwestern University Feinberg Medical School
Chicago
,
Illinois
,
United States
Councilor Since: March 1, 2010
IPC Board Member
Dr. Amy Paller is the Walter J. Hamlin Professor and Chair of Dermatology, Professor of Pediatrics, and Principal Investigator of the NIH-funded Skin Biology and Diseases Resource-based Center at Northwestern University’s Feinberg School of Medicine. She received her undergraduate and graduate degrees from Brown University and her medical degree from Stanford University. Dr. Paller completed residency training in Pediatrics and Dermatology at Northwestern University and her postdoctoral research fellowship at the University of North Carolina. An author of >750 original publications, Dr. Paller is an NIH-funded investigator conducting laboratory-based and clinical investigations related to psoriasis. Dr. Paller has led international epidemiological studies on psoriasis and atopic dermatitis, developed new tools to measure patient-related outcomes in pediatric inflammatory skin disease, and focused on psoriasis research on obesity, cutaneous innervation, and new nanotechnology-based treatment approaches. She has been the lead investigator on landmark trials in pediatric skin disease, including the first TNF inhibitor and the first IL-17 inhibitor for children with psoriasis, as well as several new topical and systemic therapies for atopic dermatitis. She has served on the Medical Advisory Board (now Emeritus) and received the Excellence in Leadership Award from the National Psoriasis Foundation (NPF). Dr. Paller has been an active IPC Councilor since 2010 and is now a member of IPC’s Board of Directors. She has served as Chair of the National Eczema Association’s Scientific and Medical Advisory Council and was co-founder and inaugural President of the International Eczema Council (IEC). She has also been President of the Society for Investigative Dermatology (SID), the Society for Pediatric Dermatology (SPD), the Pediatric Dermatology Research Alliance (PeDRA), the Women’s Dermatological Society (WDS), the International Society of Pediatric Dermatology (ISPD), and the American Dermatological Association (ADA). She has served on the Board of many national and international organizations, including the American Academy of Dermatology (AAD) and the American Board of Dermatology (ABD), and on the editorial boards of leading journals, including, currently, as Section Editor of the Journal of Investigative Dermatology (JID). She has written several textbooks, including the leading textbook for pediatric dermatology, Hurwitz Clinical Pediatric Dermatology.
Last Updated:
02/19/2026

Areas of Interest

Bench Research, Nanoconstruct Gene-Regulatory Treatments for Psoriasis, Neuroimmunology and Keratinocyte Cross-Talk in Psoriasis, Obesity-Related Impacts on Psoriasis Severity and Treatment Response, Epidemiologic Studies, Clinical Trials, Patient-Reported Outcomes Research, Pediatric Itch Assessment Tools, PROMIS Itch Questionnaire–Childhood, Stigma Measurement Tools, Pediatric Dermatology

IPC Committees / Groups

Board Member, Pediatric Global Burden Task Force, Pediatric Psoriasis Working Group

Languages Spoken

English

Involvement with Other Organization(s)

Dr. Paller participates in the National Psoriasis Foundation’s (NPF) activities and was previously an NPF medical Board Member.

What's New

Global and Collaborative Research in Psoriasis: IPC Fellows Research Class #1 Recordings

Recordings from the IPC Fellows Research Class #1: Global and Collaborative Research in Psoriasis are now available. Program Chairs Peter van de Kerkhof, MD, PhD, and María Julia Cura, MD, led a faculty of international experts through sessions on unresolved questions in the era of effective psoriasis therapies, building global research collaborations, and connecting psoriasis research across disciplines. Watch to hear from Wolf Henning Boehncke, MD, MA, Christopher Griffiths, OBE, MD, FMedSci, and Georg Stingl, MD, as they share perspectives shaping the next generation of psoriasis research.

WATCH NOW

Wednesday, July 15, 2026

New in the IPC Resource Library: Research Skills

The IPC Resource Library now includes a dedicated Research Skills category, bringing together videos, articles, and presentations focused on building stronger research capabilities in psoriasis. Browse the current collection to find resources on topics from collaborative research methods to career development for researchers at every stage.

WATCH NOW

Thursday, July 13, 2026

New Take Tens on Psoriatic Arthritis

IPC Councilor Anna Lopez Ferrer, MD, PhD, reviews PURE-4, a four-item tool that helps dermatologists screen psoriasis patients for psoriatic arthritis (PsA) risk. She traces its evolution across three studies (2018–2026) into a validated predictor of early PsA.

IPC Councilor André Lucas Ribeiro, MD, reframes PsA as a slow transition from psoriasis, not a sudden event, opening the door to disease interception. He outlines the steps needed to get there, from harmonizing definitions to reducing inflammatory burden.

WATCH NOW

Wednesday, July 8, 2026